Re: Additional Exempt Distributions

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Toinv

Rank: President [?]

Points: 4393 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Additional Exempt Distributions

in response to

Re: Additional Exempt Distributions

KOO-KOO2

posted on Oct 14, 2023 10:48AM

Thanks koo.

I'll check this out.

Cheers

Toinv

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply